Join
Live feed
·
INSIDERFilingvia Quantisnow
ADC Therapeutics SA logo

Director Azelby Robert was granted 40,000 shares, increasing direct ownership by 200% to 60,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ADCT· ADC Therapeutics SA
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADCT (ADC Therapeutics SA) and more on Quantisnow.